Pen Needles Market by Product (Safety Pen Needles, Standard Pen Needles), Length (10mm, 12mm, 4mm), Application, Mode of Purchase, Sales Channel, End-Use - Global Forecast 2024-2030

[197 Pages Report] The Pen Needles Market size was estimated at USD 1.90 billion in 2023 and expected to reach USD 2.07 billion in 2024, at a CAGR 9.55% to reach USD 3.60 billion by 2030.

Pen needles are an essential component in the administration of injectable medications for patients with chronic conditions such as diabetes, growth hormone deficiencies, and other hormonal imbalances. These fine-gauge needles are designed specifically for use with pen-style injection devices, offering a convenient and accurate method of delivering precise doses of medication in a minimally invasive manner. Individuals with diabetes rely on regular insulin injections to maintain healthy blood glucose levels. Using pen needles in combination with insulin pens allows for easy and accurate self-administration, helping to improve overall glycemic control and patient adherence to treatment regimens. One of the primary factors driving the need for the pen needles market is the increasing prevalence of diabetes worldwide. According to the International Diabetes Federation (IDF), 537 million adults (20-79 years) are living with diabetes, and is expected to rise to 643 million by 2030 and 783 million by 2045. Other factors influencing growth include increased awareness about proper diabetes management, government initiatives promoting self-monitoring practices among diabetics, and favorable reimbursement policies for medical devices in developed markets. Innovations such as safety-engineered pen needles and ultra-thin needle designs have made self-administration less painful and more effective for patients. The high cost of advanced pen needle technologies can be prohibitive for some patients, especially in developing countries where access to affordable healthcare is limited. In addition, a lack of awareness about proper disposal methods for used needles presents an environmental challenge, as improper disposal can lead to needle stick injuries and the spread of infections. Companies are focusing on innovation and research that addresses current challenges while catering to evolving consumer needs. Emerging players focus on key areas, including developing cost-effective manufacturing processes, designing ergonomically improved pens with reduced injection pain, and exploring alternative materials and coatings for enhanced comfort to enrich their business globally.

Safety pen needles are designed with safety mechanisms to prevent needlestick injuries and reduce the risk of infection. These needles are commonly used in healthcare settings and by patients with diabetes who require frequent insulin injections. Safety pen needles have become increasingly popular due to their ease of use, reduced pain, and enhanced safety features. Need-based preference for safety pen needles stems from their ability to minimize accidental pricks while disposing of used needles, ultimately promoting a safer environment for both healthcare professionals and patients. Additionally, these needles cater to people with dexterity issues or those who have difficulty handling standard pen needles. Standard pen needles are widely used for insulin injections in diabetes management and other injectable medications such as glucagon-like peptide-1 (GLP-1) agonists or growth hormone treatments. They come in various lengths and gauges to suit individual needs based on factors such as body mass index (BMI), injection site choice, and personal preferences. Standard pen needles remain popular due to their cost-effectiveness and widespread availability, but need diligent adherence to safety protocols.

Pen needles have gained popularity as an effective and convenient method for insulin injections. Shorter pen needle lengths such as 4mm, 5mm, and 6mm cater to pediatric patients and adults with lower body mass indices (BMIs). The reduced length significantly diminishes discomfort during injection while delivering an appropriate medication dosage into the subcutaneous layer. Additionally, shorter needles can be advantageous for individuals who experience anxiety or fear related to injections by reducing the visual impact and psychological distress associated with longer needle sizes. The intermediate pen needle size category comprises the 8mm variant, a versatile solution for various patients by combining effective drug delivery with reduced discomfort compared to more extended options. The 10mm and 12mm pen needles are considered longer variants, typically utilized by those with higher body fat and requiring larger insulin doses. These lengths help ensure the medication reaches subcutaneous tissue effectively, minimizing any risk associated with intramuscular injections.

OTC pen needles are purchased directly by consumers without a prescription from a medical professional. This mode of purchase is popular for individuals who require insulin injections for diabetes management and prefer easy access to pen needle supplies over visiting a healthcare provider. OTC pen needles are available in various lengths and gauges to cater to different user needs. Prescription-based pen needles require a licensed healthcare professional's authorization before being dispensed by a pharmacist. This mode of purchase ensures that patients receive appropriate guidance on the correct use of pen needles, along with personalized advice based on individual needs and circumstances. Prescription pen needle purchases often involve collaboration between manufacturers and insurance companies or government programs, wherein pricing agreements are negotiated to provide affordable options for patients requiring specific types of devices or sizes due to their medical conditions.

The offline sales channel is a primary source of pen needles for many consumers worldwide. It comprises various brick-and-mortar outlets such as hospitals, pharmacies, clinics, and retail stores. Although the online market is growing rapidly, certain factors still contribute to the preference for offline channels. Patients with chronic illnesses such as diabetes often require continuous consultation with healthcare professionals, guiding them on insulin administration techniques and recommending appropriate pen needles based on individual needs. This personalized approach helps build trust among patients toward physical stores. Some patients prefer the immediate availability of products in physical stores since it allows them to purchase pen needles on an as-needed basis without waiting for delivery times associated with online orders. The online sales channel for pen needles has been gaining traction due to benefits such as convenience, competitive pricing, and broader product availability. Online platforms include e-commerce websites, online pharmacies, and manufacturer websites. Consumers prefer the online channel primarily for convenience because they can easily compare different products and prices to make informed decisions. Online retailers often offer discounts and deals that give them a competitive edge over offline channels. Furthermore, some areas with limited access to physical stores are more likely to rely on online platforms for their pen needle requirements.

Glucagon-like peptide-1 (GLP-1) therapy involves the use of pen needles for the administration of GLP-1 receptor agonists, which help in managing blood sugar levels for patients with type 2 diabetes. The preference for pen needles in this application is due to their ease of use, minimal pain, and accurate dosage delivery. Growth hormone (GH) deficiency is treated using recombinant human growth hormone (rhGH), which requires daily subcutaneous injections. Pen needles offer an effective delivery system for this therapy due to their precise dosage control and improved adherence to the treatment regimen. Their compact design allows for convenient storage and transport, making them suitable for long-term GH replacement therapy in pediatric and adult patients with growth disorders. In recent years, pen needle technology has been adopted in hair restoration treatments such as platelet-rich plasma (PRP) therapy. PRP involves injecting concentrated platelets directly into the scalp to stimulate hair growth by enhancing angiogenesis and cellular proliferation. The accuracy and ease of penetration offered by pen needles make them an ideal choice for this minimally invasive procedure that provides promising results regarding hair regrowth. Insulin therapy is vital for managing diabetes, and pen needles are the preferred choice for many patients due to their ease of use, portability, and accuracy in insulin delivery. Pen needles are also used in microneedling procedures for skin rejuvenation and scar reduction. Microneedling devices create microscopic punctures in the skin's surface layer, triggering collagen production and promoting tissue repair. Pen needle technology offers precise control over needle depth during the treatment process, ensuring consistent results across various skin types and conditions.

In the homecare setting, patients with diabetes and other conditions requiring self-injection prefer pen needles that are easy to use, safe, and reliable. Pen needles designed for home use typically feature thin gauge sizes for minimal pain during injection, as well as safety mechanisms such as retractable needles to prevent accidental needlestick injuries. In hospitals and clinics, healthcare professionals prioritize sterility, accuracy in dosing, and efficiency when choosing pen needles. The demand for single-use disposable pen needles is high, as they reduce the risk of cross-contamination and infection. Additionally, healthcare providers prefer pen needles equipped with dose accuracy, error prevention mechanisms, and compatibility with multiple pen injectors to streamline their workflow.

The Americas region is characterized by a high incidence of diabetes among its populace, where the United States holds a significant share of the pen needles market primarily due to advanced healthcare infrastructure and reimbursement facilities. Moreover, numerous initiatives taken by public health organizations such as the American Diabetes Association (ADA) aim at increasing awareness about diabetes management tools such as insulin pens. In Canada, too, there is an upward trend in demand, which can be attributed partly to technological advancements in manufacturing processes developed by established provincial players. EU countries also play a vital role in the global pen needles market, given their established healthcare systems and well-regulated pharmaceutical industries. Rising awareness about self-management of diabetes and advancements in drug delivery technologies for growth hormone therapy have led to higher adoption of pen needles in countries such as Germany, France, and the United Kingdom. Furthermore, market growth in the Middle East and Africa is primarily driven by an increased prevalence of diabetes and improving healthcare systems. Countries such as Saudi Arabia, South Africa, and the United Arab Emirates are investing in research initiatives focused on enhancing diabetes management solutions. In the Asia-Pacific region, there is significant potential for growth in the pen needles market due to rapidly increasing diabetic populations across countries such as China, India, Japan, South Korea, and Australia. Moreover, improving healthcare infrastructure along with enhanced affordability has led to greater adoption of advanced insulin delivery devices such as insulin pens. Furthermore, increased awareness and government initiatives aimed at reducing the burden of diabetes are also anticipated to spur market growth in this region.

The FPNV Positioning Matrix is pivotal in evaluating the Pen Needles Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Pen Needles Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

• Terumo India Introduces FineGlide - Sterile Pen Needle for Patients Requiring Insulin Injections or Other Self-medications

  Pen Needles Terumo India, the Indian subsidiary of Terumo Corporation, launched FineGlide, a sterile pen needle designed to enhance patient comfort and improve compliance. FineGlide is compatible with most pen devices in India, making it highly beneficial for individuals who require regular insulin injections or other forms of self-medication. By addressing the needs of patients and healthcare providers, Terumo India aims to contribute to the overall well-being of individuals who rely on pen devices for their medical needs. [Published On: 2023-09-09]

• Novo Nordisk Enters Exclusive Negotiations to Acquire a Controlling Stake in BIOCORP, to be Followed by a Tender Offer on all Remaining Shares

  Novo Nordisk A/S and BIOCORP Production SA have entered into negotiations for a controlling stake in BIOCORP. The collaboration between Novo Nordisk and BIOCORP began in 2021, aiming to develop and commercialize Mallya. Mallya is a Bluetooth-enabled smart add-on device for pen injectors. This innovative device seeks to improve care for individuals with serious chronic diseases. [Published On: 2023-06-05]

• Montmed Inc. Announces Issuance of a Second U.S. Patent for Sitesmart Pen Needles

  Montmed, Inc. announced that the USPTO has issued a second U.S. Patent, 11,517,659, for its novel technology patent family. This patent aims to assist insulin users in easily developing and implementing healthy injection site rotation practices. The newly issued patent integrates distinctive marks and user-defined associations in digital devices or software, enhancing the user experience and ensuring optimal injection practices. [Published On: 2023-02-22]

The report delves into recent significant developments in the Pen Needles Market, highlighting leading vendors and their innovative profiles. These include AdvaCare Pharma, Advocate by Pharma Supply, Inc., Allison Medical, Inc., ARKRAY, Inc., Ayset Health Services, B. Braun SE, Becton, Dickinson and Company, Berpu Medical Technology Co., Ltd., Cardinal Health, Inc., F. Hoffmann-La Roche Ltd., Gan & Lee Pharmaceuticals Co., Ltd., GlucoRx Ltd., Hindustan Syringes & Medical Devices Ltd., IME-DC GmbH, Jiangsu Micsafe Medical Technology Co., Ltd., Jinan Babio Biotechnology Co., Ltd., Lepu Medical Technology (Beijing) Co., Ltd., Medexel Co., Ltd., Medical Technology and Devices S.p.A., MEDISEC Healthcare, Montméd Inc., Narang Medical Limited, Neon Diagnostics Ltd., Nipro Corporation, Novo Nordisk A/S, Owen Mumford Limited, Promisemed Medical Devices Inc., Shanghai Berpu Medical Co., Ltd, Shanghai Kindly Enterprise Development Group, Sol-Millennium, Spirit Healthcare Pty Ltd., Terumo Corporation, Trividia Health, Inc., UltiMed, Inc., Van Heek Medical, Vitrex Medical A/S, Vogt Medical Vertrieb GmbH, Ypsomed Holding AG, and Zibo Sunrise Medical Co., Ltd..

This research report categorizes the Pen Needles Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Product
  • Safety Pen Needles
  • Standard Pen Needles
• Length
  • 10mm
  • 12mm
  • 4mm
  • 5mm
  • 6mm
  • 8mm
• Application
  • GLP-1 Therapy
  • Growth Hormone Therapy
  • Hair Treatment
  • Insulin Therapy
  • Skin Treatment
• Mode of Purchase
  • OTC
  • Prescription
• Sales Channel
  • Offline
  • Online
• End-Use
  • Homecare
  • Hospitals & Clinics

• Region
  • Americas
    • Argentina
    • Brazil
    • Canada
    • Mexico
    • United States
      • California
      • Florida
      • Illinois
      • New York
      • Ohio
      • Pennsylvania
      • Texas
  • Asia-Pacific
    • Australia
    • China
    • India
    • Indonesia
    • Japan
    • Malaysia
    • Philippines
    • Singapore
    • South Korea
    • Taiwan
    • Thailand
    • Vietnam
  • Europe, Middle East & Africa
    • Denmark
    • Egypt
    • Finland
    • France
    • Germany
    • Israel
    • Italy
    • Netherlands
    • Nigeria
    • Norway
    • Poland
    • Qatar
    • Russia
    • Saudi Arabia
    • South Africa
    • Spain
    • Sweden
    • Switzerland
    • Turkey
    • United Arab Emirates
    • United Kingdom

1. Market Penetration: It presents comprehensive information on the market provided by key players.
2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

1. What is the market size and forecast of the Pen Needles Market?
2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Pen Needles Market?
3. What are the technology trends and regulatory frameworks in the Pen Needles Market?
4. What is the market share of the leading vendors in the Pen Needles Market?
5. Which modes and strategic moves are suitable for entering the Pen Needles Market?